The AUSCO study assessed the artificial urinary sphincter's impact on incontinence and quality of life in men post-prostate surgery or with other urinary issues. Conducted across 18 sites, the study ...
The study involved a large international, multi-center cohort of approximately 4,000 patients undergoing inflatable penile prosthesis surgery. No significant differences in intraoperative or ...
Aquablation with the HYDROS System integrates AI, cystoscopic, and ultrasonic imaging for personalized treatment planning in benign prostatic hyperplasia. Understanding transrectal ultrasonography, ...
mCSPC treatment requires personalized approaches, considering disease burden, patient comorbidities, and genetic profiles to optimize outcomes. There is a significant need for more effective ...
ALLO-316 demonstrates significant anti-tumor activity in CD70-positive advanced ccRCC, with a 50% overall response rate in high CD70 expression patients. The therapy maintains a manageable safety ...
Prostate cancer treatment is linked to a higher risk of long-term complications, persisting up to 12 years post-treatment. The study utilized data from large preventative trials, comparing treated and ...
The phase 3 ENVISION trial met its primary end point by demonstrating a 79.6% complete response rate at 3 months following the first instillation of the therapy.
Patient satisfaction is high due to the adaptive delivery of information and encouragement of feedback. Jenson incorporates common patient concerns into lectures, ensuring comprehensive information ...